IFM Investors Pty Ltd raised its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 4.3% in the 1st quarter, HoldingsChannel.com reports. The firm owned 135,115 shares of the conglomerate’s stock after purchasing an additional 5,605 shares during the period. IFM Investors Pty Ltd’s holdings in Danaher were worth $25,618,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. JPL Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher during the fourth quarter valued at approximately $26,000. WFA of San Diego LLC purchased a new position in Danaher during the second quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new position in shares of Danaher in the fourth quarter worth approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
Several analysts have recently commented on DHR shares. Piper Sandler started coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. Evercore increased their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Guggenheim decreased their price target on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Jefferies Financial Group restated a “buy” rating and issued a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. Finally, Weiss Ratings lowered Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.61.
Danaher Price Performance
DHR stock opened at $190.26 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company’s fifty day moving average price is $178.72 and its 200-day moving average price is $201.03. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a market capitalization of $134.66 billion, a PE ratio of 36.80, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the firm posted $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities analysts anticipate that Danaher Corporation will post 8.44 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio is presently 30.95%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
